Inside the research
Healthcare Realty Trust Incorporated
HR Research profile · latest available data
Price overview
$18.05
▲ +0.22 (+1.2%)
| 52w hi | $21.60 |
|---|---|
| 52w lo | $15.74 |
| Vol | 4.02M |
| As of | 25 Sep 2026 |
The Verdict
Our score -0.58
| Short | -0.13 |
|---|---|
| Medium | -0.71 |
| Long | -1.19 |
computed 2026-09-27
Key fundamentals
Healthcare Realty Trust Incorporated
Real Estate · REIT - Healthcare Facilities
| Market cap | $6.26B |
|---|---|
| Enterprise value | $10.62B |
| Forward P/E | 257.86x |
| EV / EBITDA | 15.14x |
| P / S (ttm) | 5.51x |
| Profit margin | -7.6% |
| Return on equity | -1.9% |
| Revenue growth | -4.3% |
| Debt / equity | 103.03 |
Layer Breakdown
| Layer | Raw | Contribution |
|---|---|---|
| Fundamental | -0.18 | |
| Sector | -0.04 | |
| Technical | -0.24 | |
| Earnings | +0.00 | |
| Sentiment | +0.00 |
macro × 1.00 · 2026-09-27
Business overview
Healthcare Realty Trust Incorporated is a real estate investment trust (REIT) that owns and operates medical outpatient buildings primarily located around market-leading hospital campuses. The Company selectively grows its portfolio through property acquisition and development. As of September 30, 2025, the Company was invested in 579 real estate properties in 28 states totaling 33.6 million square feet and had an enterprise value of approximately 11.1 billion dollars, defined as equity market capitalization plus the principal amount of debt less cash. Healthcare Realty Trust Incorporated was incorporated in 1992 and is based in Nashville, United States.
Risk Metrics
| Beta vs SPX | 0.27 |
|---|---|
| Corr SPX | 0.20 |
| Annual vol | 21.9% |
| Annual ret | +2.7% |
| Sharpe | 0.12 |
| Max DD | -23.6% |
Window: 504 trading days (504 obs)
Material Events
| Date | Event | 8-K |
|---|---|---|
| 2026-07-31 | Other Material Event, Exhibits | read |
| 2026-07-30 | Earnings Release, Reg FD Disclosure… | read |
| 2026-05-20 | Shareholder Vote | read |
| 2026-05-19 | Material Agreement, Material Obligation… | read |
| 2026-05-07 | Material Agreement, Material Obligation… | read |
| 2026-05-05 | Other Material Event, Exhibits | read |
| 2026-04-30 | Earnings Release, Reg FD Disclosure… | read |
| 2026-02-27 | Reg FD Disclosure, Exhibits | read |
| 2026-02-23 | Auditor Change, Exhibits | read |
| 2026-02-12 | Earnings Release, Reg FD Disclosure… | read |
| 2026-01-07 | Officer / Director Change, Reg FD Disclosure… | read |
| 2025-12-17 | Material Agreement, Exhibits | read |
Insider Trades
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-23 | Callaway Amanda L | SVP & Chief Accounting Of | Sell | 25.77K | $524.87K |
| 2026-05-19 | Bohjalian Thomas N | Grant | 6.68K | $135.00K | |
| 2026-05-19 | HENRY DAVID | Grant | 6.68K | $135.00K | |
| 2026-05-19 | MOORE CONSTANCE B | Grant | 6.68K | $135.00K | |
| 2026-05-19 | RUFRANO GLENN J | Grant | 6.68K | $135.00K | |
| 2026-05-19 | WOOD DONALD C | Grant | 6.68K | $135.00K | |
| 2026-04-14 | Scott Peter A | President and CEO | Withheld for tax | 36.03K | $642.76K |
| 2026-03-06 | Bohjalian Thomas N | Buy | 10.00K | $180.90K | |
| 2026-03-04 | Gabbay Daniel | EVP, Chief Financial Offi | Buy | 10 | $187 |
| 2026-02-09 | Gabbay Daniel | EVP, Chief Financial Offi | Grant | 32.11K | $549.99K |
Flow & Concentration
| Insider 180d net | -$524.87K |
|---|---|
| Insider buys / sells | 0 / 1 |
| Insider bias | Neutral |
| 13F holders | 0 |
| Top-5 share | 0.0% |
| HHI | 0 (—) |
Dividends
| Yield (TTM) | 2.66% |
|---|---|
| $ / share (TTM) | $0.48 |
| 5y CAGR | -12.5% |
Annual dividend per share
| 2021 | $2.50 |
|---|---|
| 2022 | $7.04 |
| 2023 | $1.24 |
| 2024 | $1.24 |
| 2025 | $1.10 |
| 2026 | $0.24 |
SEC Filings
The Long Run
FY 2011–2025 · 15 years
| Line | Latest | CAGR | Trend |
|---|---|---|---|
| Revenue | $28.21M | -10.3% | |
| Operating income | $123.65M | +17.4% | |
| Net income | -$278.26M | +33.0% | |
| Cash from ops | $457.10M | +24.3% |
Indices
Recent Sessions
| Date | Open | High | Low | Close | Vol |
|---|---|---|---|---|---|
| Sep 25 | $17.74 | $18.10 | $17.67 | $18.05 | 4.02M |
| Sep 24 | $18.03 | $18.15 | $17.79 | $17.83 | 5.05M |
| Sep 23 | $18.09 | $18.17 | $17.95 | $17.96 | 5.17M |
| Sep 22 | $18.31 | $18.46 | $18.16 | $18.18 | 4.39M |
| Sep 21 | $18.29 | $18.35 | $18.13 | $18.27 | 5.55M |
Understand the score. Research layers are inputs to a model, and the available data has limits.
Read the methodology →